| CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
| 2241014-82-2 | NAMPT inhibitor-linker 2
| |
C34H33FN6O5 | 624.66 |
| 2241019-57-6 | NAMPT inhibitor-linker 1
| |
C36H37FN6O6 | 668.71 |
| 1164469-60-6 | Naftopidil hydrochloride
| |
C24H29ClN2O3 | 428.96 |
| 184674-99-5 | NAD 299盐酸盐
NAD 299 hydrochloride | |
C18H23FN2O2.HCl | 354.85 |
| 1452458-86-4 | Nacubactam
| |
C9H16N4O7S | 324.31 |
| 2089293-61-6 | NAcM-OPT
| |
C23H29Cl2N3O | 434.40 |
| 1394371-75-5 | nAChR agonist 1
| |
C20H18ClNO3S2 | 419.940 |
| 1005307-86-7 | N6-(2-Dimethylamino-ethyl)-N4-(3,4-dimethyl-phenyl)-1-phenyl-1H-pyrazolo[3,4-d]pyrimidine-4,6-diamine
PR5-LL-CM01 | |
C23H27N7 | 401.51 |
| 1884222-74-5 | N4-环丙基-N2-(3,4-二甲氧基苯基)-5-(三氟甲基)嘧啶-2,4-二胺
N4-cyclopropyl-N2-(3,4-dimethoxyphenyl)-5-(trifluoromethyl)pyrimidine-2,4-diamine | |
C16H17F3N4O2 | 354.33 |
| 195822-23-2 | N2，N3-双(4-氟苯基)喹喔啉-2，3-二胺
LQZ-7I | |
C20H14F2N4 | 348.35 |
| 792184-90-8 | N2-(4-fluorophenyl)-N4-phenyl-N6-(pyrimidin-2-ylmethyl)-1,3,5-triazine-2,4,6-triamine
ASP2905 | |
C20H17FN8 | 388.4 |
| 912569-84-7 | N2'-Deacetyl-N2'-[3-(methylthio)-1-oxopropyl]-maytansine
S-methyl DM1 | |
C36H50ClN3O10S | 752.31 |
| 230971-71-8 | N1氯沙坦基氯沙坦(氯沙坦杂质)
N1-Losartanyl-losartan (Losartan Impurity) | |
| |
| 917572-74-8 | N1,N16-双十二烷基-4,7,13-三(3-(十二烷基氨基)-3-氧代丙基)-4,7,10,13-四氮杂十六烷二酰胺
N1,N16-Didodecyl-4,7,13-tris(3-(dodecylamino)-3-oxopropyl)-4,7,10,13-tetraazahexadecanediamide | |
C81H163N9O5 | 1343.22 |
| 1454902-97-6 | N-羟基-4-((3-(2-甲氧基苯基)脲基)甲基)苯甲酰胺
N-Hydroxy-4-((3-(2-methoxyphenyl)ureido)methyl)benzamide | 密度：1.328±0.06 g/cm3(Predicted)
|
C16H17N3O4 | 315.32 |
| 940005-81-2 | N-溴乙酰基-三聚乙二醇-叠氮
Bromoacetamido-PEG4-azido | |
C10H19BrN4O4 | 339.19 |
| 1264015-76-0 | N-叔丁氧羰基-六聚乙二醇-对甲苯磺酸酯
2,2-Dimethyl-4-oxo-3,8,11,14,17,20-hexaoxa-5-azadocosan-22-yl 4-methylbenzenesulfonate | |
C24H41NO10S | 535.65 |
| 2222112-77-6 | N-[反式-4-(3-氯-4-氰基苯氧基)环己基]-6-[4-[[4-[2-(2, 6-二氧-3-哌啶基)-6-氟] -2, 3-二氢-1, 3-二氧-1H-异吲哚-5-基]-1-哌嗪基]甲基]-1-哌啶基]-3-哒嗪甲酰胺
N-((1R, 4R)-4-(3-Chloro-4-cyanophenoxy)cyclohexyl)-6-(4-((4-(2-(2, 6-dioxopiperidin-3-yl)-6-fluoro-1, 3-dioxo-2, 3-dihydro-1H-isoindol-5-yl)piperazin-1-yl)methyl)piperidin-1-yl)pyridazine-3-carboxamide | |
C41H43ClFN9O6 | 812.29 |
| 1404437-49-5 | N-[3-methoxy-4-(4-methyl-1-piperazinyl)phenyl]-1-(4-methoxyphenyl)-6-pyrazolo[3,4-d]pyrimidinamine
STK33-IN-1 | |
C24H27N7O2 | 455.52 |
| 154563-54-9 | N-[3,5-Bis(trifluoromethyl)phenyl]-2-chloro-4-(trifluoromethyl)-5-pyrimidinecarboxamide
SP-100030 | |
C14H5ClF9N3O | 437.65 |
| 2055918-71-1 | N-[2-[5-Amino-1-[6-(2,6-difluorophenoxy)-4-methylpyridin-3-yl]pyrazole-4-carbonyl]-5-methyl-1H-indol-6-yl]methanesulfonamide
| |
C26H22F2N6O4S | 552.55 |
| 2660250-10-0 | N-[2-[(3S,4R)-3-氟-4-甲氧基-1-哌啶基]-4-嘧啶基]-5-异丙基-8-[(2R,3S)-2-甲基-3-[(甲砜基)甲基]-1-氮杂环丁基]异喹啉-3-胺
N-(2-((3S,4R)-3-fluoro-4-methoxypiperidin-1-yl)pyrimidin-4-yl)-5-isopropyl-8-((2R,3S)-2-methyl-3-((methylsulfonyl)methyl)azetidin-1-yl)isoquinolin-3-amine | |
C28H37FN6O3S | 556.705 |
| 1097624-48-0 | N-[1-[(2,3-Dihydro-1H-indol-1-yl)carbonyl]-2-methylbutyl]benzamide
| |
C21H24N2O2 | 336.43 |
| 145961-79-1 | N-[(1S,2R)-2-(4-hydroxyphenyl)-2,3-dihydro-1H-inden-1-yl]-2,2-diphenylacetamide
ACAT-IN-1 cis isomer | |
C29H25NO2 | 419.52 |
| 2226541-13-3 | N-[(1S)-1-[[(2S)-2-[5-[4'-[2-[(2S)-1-Acetyl-2-pyrrolidinyl]-1H-imidazol-5-yl][1,1'-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl ester carbamic acid
Daclatasvir Impurity B | |
C35H41N7O4 | 623.74 |
| 216596-71-3 | N-undecanoyl-L-Homoserine lactone
N-undecanoyl-L-Homoserine lactone (C11-HSL) | |
C15H27NO3 | 269.4 |
| 878627-21-5 | N-tridecanoyl-L-Homoserine lactone
N-tridecanoyl-L-Homoserine lactone (C13-HSL) | |
C17H31NO3 | 297.4 |
| 2231747-18-3 | N-piperidine Ibrutinib hydrochloride
| |
C22H23ClN6O | 422.91 |
| 55154-48-8 | N-phenylacetyl-L-Homoserine lactone
| |
C12H13NO3 | 219.2 |
| 182359-66-6 | N-pentadecanoyl-L-Homoserine lactone
N-pentadecanoyl-L-Homoserine lactone (C15-HSL) | |
C19H35NO3 | 325.5 |
| 83982-06-3 | N-Palmitoyl Taurine
| |
C18H37NO4S | 363.6 |
| 60374-41-6 | N-Oleoyl Valine
| |
C23H43NO3 | 381.6 |
| 52514-04-2 | N-Oleoyl Taurine
| |
C20H39NO4S | 389.6 |
| 925891-74-3 | N-Octadecyl-N'-propyl-sulfamide
| |
C21H46N2O2S | 390.7 |
| 1260431-01-3 | N-Methyl-n-(t-boc)-peg4-acid
| |
C17H33NO8 | 379.45 |
| 2107273-22-1 | N-Methyl-N'-(hydroxy-PEG2)-Cy5
| |
C32H41ClN2O3 | 537.13 |
| 2055014-77-0 | N-Me-n-bis(peg4acid)
| |
C23H45NO12 | 527.6 |
| 2055046-22-3 | N-Me-n-bis(peg3-oh)
| |
C17H37NO8 | 383.48 |
| 342818-95-5 | N-Me-n-bis(peg2-oh)
| |
C13H29NO6 | 295.37 |
| 1835759-84-6 | N-Me-n-(peg2-propargyl)2
| |
C15H25NO4 | 283.36 |
| 2128735-27-1 | N-Mal-n-bis(peg4-nh-boc)
| |
C37H66N4O15 | 806.940 |
| 2128735-22-6 | N-Mal-N-bis(PEG4-amine)
| |
C27H50N4O11 | 606.71 |
| 2100306-51-0 | N-Mal-n-bis(peg2-t-butyl ester)
| |
C29H48N2O11 | 600.7 |
| 2182601-73-4 | N-Mal-n-bis(peg2-nhs ester)
| |
C29H38N4O15 | 682.63 |
| 2128735-26-0 | N-Mal-n-bis(peg2-nh-boc)
| |
C29H50N4O11 | 630.73 |
| 807370-75-8 | N-Lignoceroyl Taurine
| |
C26H53NO4S | 475.8 |
| 22235-81-0 | N-Isopropylnoratropine
N-Isopropylnoratropine (NINA) | |
C19H27NO3 | 317.4 |
| 87206-01-7 | N-hexadecanoyl-L-Homoserine lactone
| |
C20H37NO3 | 339.5 |
| 2353409-60-4 | N-Desthiobiotin-N-bis(PEG4-t-butyl ester)
| |
C40H75N3O14 | 822.04 |
| 2353409-61-5 | N-Desthiobiotin-N-bis(PEG4-NHS ester)
| |
C40H65N5O18 | 903.97 |
